WallStSmart

i3 Verticals Inc (IIIV)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

i3 Verticals Inc generates 13% more annual revenue ($293.02M vs $258.90M). IIIV leads profitability with a -2.0% profit margin vs -15.5%. IIIV earns a higher WallStSmart Score of 43/100 (D).

IIIV

Hold

43

out of 100

Grade: D

Growth: 3.3Profit: 3.5Value: 6.0Quality: 7.5
Piotroski: 3/9Altman Z: 3.36

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

IIIVUndervalued (+47.7%)

Margin of Safety

+47.7%

Fair Value

$41.85

Current Price

$22.55

$19.30 discount

UndervaluedFair: $41.85Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

IIIV3 strengths · Avg: 10.0/10
Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.3610/10

Safe zone — low bankruptcy risk

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

IIIV4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.9%4/10

0.9% revenue growth

Market CapQuality
$477.23M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.8%3/10

ROE of 0.8% — below average capital efficiency

Operating MarginProfitability
2.5%3/10

Operating margin of 2.5%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : IIIV

The strongest argument for IIIV centers on Price/Book, Debt/Equity, Altman Z-Score. PEG of 1.24 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : IIIV

The primary concerns for IIIV are Revenue Growth, Market Cap, Return on Equity. A P/E of 270.0x leaves little room for execution misses.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

IIIV profiles as a turnaround stock while ZEPP is a hypergrowth play — different risk/reward profiles.

ZEPP carries more volatility with a beta of 1.77 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive dynamics, and regulatory changes.

Bottom Line

IIIV scores higher overall (43/100 vs 41/100). ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Hold" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

i3 Verticals Inc

TECHNOLOGY · SOFTWARE - INFRASTRUCTURE · USA

i3 Verticals, Inc. provides integrated payment and software solutions to small and medium-sized businesses and organizations in the education, nonprofit, public sector, property management, and healthcare markets in the United States. The company is headquartered in Nashville, Tennessee.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?